INVO Fertility shares surge 10.66% after-hours as leadership changes bolster clinic-acquisition growth strategy.

INVO Fertility surged 10.66% in after-hours trading following announcements of leadership changes and a strategic realignment to accelerate growth. The company appointed Terah Krigsvold as CFO, replacing Andrea Goren, who was elevated to chief business officer and CEO of INVO Centers LLC, its clinic subsidiary. These moves, effective Dec. 30, 2025, aim to streamline operations by having Goren focus on acquisitions and clinic expansions while ensuring financial continuity under Krigsvold. CEO Steve Shum emphasized the changes strengthen execution of the growth strategy, citing Goren’s $1 billion in transaction experience and Krigsvold’s seven-year tenure. The news reinforced confidence in management’s ability to scale the business, particularly through the acquisition of Family Beginnings, P.C., a fertility clinic in Indiana, and the expansion of INVO Centers. The market interpreted the leadership upgrades as a signal of operational discipline and growth momentum, driving the sharp after-hours rally.